Aircraft registration

Better Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates

Retrieved on: 
Thursday, November 9, 2023
Health, Diabetes, Neurology, Health Technology, Pharmaceutical, Cardiology, Biotechnology, FDA, Insurance, Standard of care, Research, Trial of the century, American College, First, Aircraft registration, American Gastroenterological Association, FSS, PDT, Food, AGA, Patent, ATM, Therapy, Regulation, Business development, Disclosure, Regulation of tobacco by the U.S. Food and Drug Administration, Type 2 diabetes, Marketing, Partnership, Webcast, Machine learning, Regulation Fair Disclosure, Better, Traction, CBT, Safety, AI, European, MASH, Patient, Prescription, Veteran, VA, Cognitive behavioral therapy, Pharmaceutical industry, Health insurance, Bank, T2D, EU

New Patent Issued: In September 2023, Better Therapeutics patent - "Managing lifestyle and health interventions with predictive analytics" - was issued in the European Union (EU).

Key Points: 
  • New Patent Issued: In September 2023, Better Therapeutics patent - "Managing lifestyle and health interventions with predictive analytics" - was issued in the European Union (EU).
  • Showcased AspyreRx at First Promotional Meeting: In October 2023, Better Therapeutics announced its participation at the American College of Lifestyle Medicine’s 2023 Annual Meeting.
  • Further Strengthen Financial Position: Better Therapeutics expects to further strengthen its financial position in the fourth quarter to extend its financial runway.
  • Better Therapeutics periodically provides other information for investors on its corporate website, http://www.bettertx.com , and its investor relations website, https://investors.bettertx.com .

3iQ, Coinbase and Tetra Trust Joining Forces to Advance the Crypto ETP Space in Canada and Generate Additional Interest from Investor Community

Retrieved on: 
Wednesday, September 21, 2022
Tetra, Bitcoin, Odyssey, Adoption, TSX, ETP, T+2, BTCQ, Digital asset management, Company, Partnership, Industry, Canadian Securities Exchange, ETF, CEO, Technology, National, Board of directors, Leadership, Aircraft registration, Ecosystem, Insurance, NASDAQ, Government, Board, National instrument, Disclosure, Cryptocurrency, Security (finance), Coinbase

TORONTO, Sept. 21, 2022 /PRNewswire/ -- 3iQ Digital Asset Management (3iQ) together with Coinbase and Tetra Trust Company ("Tetra Trust" or "Tetra") are pleased to announce a new partnership aimed at expanding the exchange-traded product (ETP) ecosystem for digital assets in Canada and generating new interest from the investment community.

Key Points: 
  • 3iQ has also selected Coinbase Prime to provide crypto trading, prime brokerage and reporting capabilities for its crypto ETP products.
  • We look forward to introducing new strategies and supporting cutting-edge products while working to strengthen the overall crypto landscape."
  • "Coinbase is proud to be partnering with 3iQ as their exclusive prime broker and as a custodian partner along with Tetra," said Steve Capozza, Director of Coinbase Institutional Sales.
  • "Tetra is excited to be working with 3iQ and Coinbase to create a superior custody model for the Canadian crypto ETP segment," said Didier Lavalle, CEO of Tetra Trust.

Twist Bioscience Highlights Synthetic Libraries and High Throughput Antibody Discovery Platform at PEGS Boston 2022

Retrieved on: 
Monday, May 2, 2022
Health, Biotechnology, CAR, Antibody, Proteinogenic amino acid, Epitope, VHH, U.S. Securities and Exchange Commission, Forward-looking statement, Private Securities Litigation Reform Act, Hynes Convention Center station, Agriculture, Immunoglobulin G, RNA transfection, Library, NASDAQ, SVP, Phoenix Carnegie Library and Library Park, Engineering, Martek Biosciences Corporation, Cell, NGS, Doctor of Philosophy, Patient, Twist Bioscience, Drug discovery, Gene editing, Risk, PEGS, ELISA, Therapy, Synthetic biology, Aircraft registration, Concurrent use registration, DNA, Genomics, ADORA2A, Hynes Convention Center, Security (finance), Silicon, TCR, Immunization, CRISPR, SEC, Hyperimmune, CEO, Protein, Technology, Biology, Humanized antibody, Vaccine, Antibiotics

These posters show the depth and breadth of the antibody discovery and library construction capabilities of Twist Biopharma against high-impact targets, said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience.

Key Points: 
  • These posters show the depth and breadth of the antibody discovery and library construction capabilities of Twist Biopharma against high-impact targets, said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience.
  • Our next generation libraries enable antibody discovery for therapies such as CAR-T engineered cell therapies, which have the potential to change the treatment landscape for patients.
  • In addition, the data presented on the discovery of an antibody targeting ADORA2A, a next generation checkpoint, demonstrate Twist Biopharmas ability to generate antibodies independently.
  • Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development.

Tetra Trust Announces Custody Agreement with Accelerate

Retrieved on: 
Wednesday, April 27, 2022
Tetra, CryptoPunks, CEO, Board, NFT, Government, Nate Glubish, Acceleration, Element, Exempt market dealer, Board of directors, GLOBE, Decentralized finance, Non-fungible token, Company, Solution, Aircraft registration, National instrument, Canadian Securities Exchange, Safety, ETF, Industry, Partnership, Executive Council of Alberta, Blockchain, Cryptocurrency, Security (finance), Coinbase

CALGARY, Alberta, April 27, 2022 (GLOBE NEWSWIRE) -- Accelerate Financial Technologies Inc. (Accelerate), a leader in alternative investment solutions, announced today it has selected Tetra Trust Company (Tetra Trust or Tetra) to custody Accelerates digital assets.

Key Points: 
  • CALGARY, Alberta, April 27, 2022 (GLOBE NEWSWIRE) -- Accelerate Financial Technologies Inc. (Accelerate), a leader in alternative investment solutions, announced today it has selected Tetra Trust Company (Tetra Trust or Tetra) to custody Accelerates digital assets.
  • We are very pleased to enter into an agreement with Tetra Trust to offer institutional-caliber custody of our digital assets, including for our new NFT fund, said Julian Klymochko, Founder and CEO of Accelerate.
  • By leveraging its partnership with Knox Custody, Tetra is able to offer the first institutional-grade custody solution for NFTs.
  • We expect to provide custody for additional Accelerate digital asset offerings beyond the NFT fund as we further develop our relationship.

Tetra Trust Appoints Didier Lavallée as CEO to Lead Acceleration of Crypto Custody in Canada

Retrieved on: 
Monday, April 11, 2022
Tetra, Company, Canadian Securities Exchange, Leadership, Growth, Board, Government, Royal Bank, UBS, FX, National instrument, Board of directors, Exempt market securities, American, Industry, GLOBE, Solution, RBC, Royal Bank of Canada, Aircraft registration, Cryptocurrency, Coinbase

CALGARY, Alberta, April 11, 2022 (GLOBE NEWSWIRE) -- Tetra Trust Company (Tetra Trust, Tetra or the Company), Canadas first qualified custodian for digital assets, today announced that its Board of Directors has appointed Didier Lavalle as Chief Executive Officer, effective April 19, 2022.

Key Points: 
  • CALGARY, Alberta, April 11, 2022 (GLOBE NEWSWIRE) -- Tetra Trust Company (Tetra Trust, Tetra or the Company), Canadas first qualified custodian for digital assets, today announced that its Board of Directors has appointed Didier Lavalle as Chief Executive Officer, effective April 19, 2022.
  • Lavalle is an accomplished financial services executive with more than 15 years of experience in the capital markets and custody sectors, most recently as Head of Product, Custody Canada at Royal Bank of Canada.
  • Custody is the backbone of a strong digital asset marketplace and Tetra is well positioned to lead in this emerging asset class.
  • Lavalle joins Tetra as the Company begins to accelerate its growth and increase the amount of digital assets under management.

Arterys Signs Global Distribution Agreement With iCAD, Inc. to Launch Its New Breast AI SaaS Solution

Retrieved on: 
Tuesday, November 30, 2021
Patient, Profound Pharma, Efficiency, Technology, AI, ICAD, Conant, Partnership, Anatomy, Tomosynthesis, Radiology, Breast, SAN, Solution, Aircraft registration, 2D, Breast cancer, Magic: The Gathering core sets, 1993–2007, DBT, Commercialization, 3D, Artificial intelligence, Risk, GLOBE, Incidence, FDA, Mammography, Internet, MICA, Medical device, Medical imaging

SAN FRANCISCO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Arterys, the world's leading vendor-neutral AI platform, today announced it signed a global distribution agreement with iCAD , a global medical technology leader providing innovative cancer detection and therapy solutions.

Key Points: 
  • SAN FRANCISCO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Arterys, the world's leading vendor-neutral AI platform, today announced it signed a global distribution agreement with iCAD , a global medical technology leader providing innovative cancer detection and therapy solutions.
  • This partnership will expand access to iCAD's industry-leading AI-powered breast health solutions via Arterys' FDA-cleared and CE-marked MICA platform to its installed base.
  • "Arterys is not an AI Marketplace company but an AI Platform company where we bring only the best-of-breed AI solutions together to work seamlessly within one user interface.
  • ProFound AI for DBT was the first AI cancer detection software for DBT to be cleared by the FDA.

Akoya Biosciences Secures CLIA Lab Certification, a Milestone for Applying Its Spatial Biology Technologies to Accelerating Precision Cancer Therapies

Retrieved on: 
Tuesday, November 30, 2021
Security (finance), Massachusetts Department of Public Health, Biomarker, Forward-looking statement, Biology, Health, Public, Workflow, Solution, U.S. Securities and Exchange Commission, AstraZeneca, Program, Aircraft registration, Nasdaq, Neoplasm, GLOBE, Terminology, Akoya, HIV disease progression rates, Science, Journal, Public health, Clinical Laboratory, ABS, CLIA, Growth, Medical imaging, Pharmaceutical industry

MARLBOROUGH, Mass., Nov. 30, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, today announced that its Advanced Biopharma Solutions (ABS) laboratory, located in Marlborough, Massachusetts, has received its Certificate of Registration from the Clinical Laboratory Improvement Amendments (CLIA) program, following the receipt of a Massachusetts Department of Public Health clinical laboratory license. This certification enables Akoya’s ABS lab to support later stage clinical trial studies with its biopharmaceutical partners.

Key Points: 
  • This certification enables Akoyas ABS lab to support later stage clinical trial studies with its biopharmaceutical partners.
  • It further positions Akoya Biosciences as an attractive partner for biopharmaceutical companies seeking to incorporate its ground-breaking spatial biology technologies into their clinical research, most notably in the expanding field of cancer immunotherapy.
  • Securing CLIA certification for ABS demonstrates our commitment to meeting the highest quality standards, said Brian McKelligon, Chief Executive Officer of Akoya Biosciences.
  • As The Spatial Biology Company, Akoya Biosciences (Nasdaq: AKYA) mission is to bring context to the world of biology and human health through the power of spatial phenotyping.

Tetra Trust Partners with Global Leader Ledger Enterprise Solutions To Secure Digital Assets for Institutional Clients

Retrieved on: 
Tuesday, October 19, 2021
Tetra, Exempt market dealer, CSE, Certification, Â, Canadian Securities Exchange, Growth, SOC, Ministry, Insurance, CEO, Aircraft registration, GLOBE, Industry, Solution, National instrument, Coinbase, Cryptocurrency

CALGARY, Alberta, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Tetra Trust Company, Canadas only qualified custodian for digital assets, announced today that it has entered into an agreement with digital asset security firm, Ledger Enterprise Solutions, to secure digital assets for institutional clients.

Key Points: 
  • CALGARY, Alberta, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Tetra Trust Company, Canadas only qualified custodian for digital assets, announced today that it has entered into an agreement with digital asset security firm, Ledger Enterprise Solutions, to secure digital assets for institutional clients.
  • Founded in 2021, Ledger Enterprise Solutions is a division of Ledger, the global leader in security and infrastructure solutions for safeguarding critical digital assets.
  • The mission of Ledger Enterprise Solutions is to enable the digital assets industry to become a multi-trillion dollar industry globally.
  • Ledger Enterprise Solutions provides enterprise-grade security technology solutions and services for custodians, exchanges, banks, and traditional financial institutions.

ImageCare Centers Unveils PINK Better Mammo Service, Featuring Profound AI®, the World’s First FDA Cleared Artificial Intelligence Solution for 3D Mammography

Retrieved on: 
Thursday, September 16, 2021
Oncology, Health, Consumer, Technology, Women, Software, Radiology, Calcification, Cancer, CT, Artificial intelligence, Tomosynthesis, Reading, Conant, FDA, Efficiency, 3D, Technology, Health, Radiology, Magnetic resonance imaging, 2D, Adoption, Patient, PET/CT, Aircraft registration, Profound Pharma, Malignancy, Software, X-ray, Warren County School District, ICAD, Workflow, Solution, CAD, MD, Breast cancer, DBT, Multimedia, Mammography, Central Jersey, Woman, Paediatric radiology, Medical imaging, Medical device, ImageCare Centers, iCAD, Inc., IMAGECARE CENTERS, ICAD, INC.

ImageCare Centers is unveiling its new PINK Better Mammo service with the addition of ProFound AI for Digital Breast Tomosynthesis (DBT).

Key Points: 
  • ImageCare Centers is unveiling its new PINK Better Mammo service with the addition of ProFound AI for Digital Breast Tomosynthesis (DBT).
  • View the full release here: https://www.businesswire.com/news/home/20210916005258/en/
    PINK Breast Center, the womens health services arm of ImageCare Centers, has been using ProFound AI since September 2019.
  • The technology has improved workflow and reading accuracy at the facility since adoption, offering benefits to both clinicians and patients.
  • As soon as we implemented ProFound AI, we started using it on all of our DBT breast cancer screenings.

Tetra Trust Company Welcomes Glenn Goucher, Jon Varley to Leadership Team

Retrieved on: 
Tuesday, September 14, 2021
Tetra, Aircraft registration, CEO, Technology, National instrument, Ecosystem, Canadian Securities Exchange, VP, Exempt market dealer, CSE, CDS, Ministry, GLOBE, Derivative, History, Cryptocurrency, Financial services

CALGARY, Alberta, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Tetra Trust Company, Canada’s only regulated financial institution focused on cryptocurrency assets, announced today that Glenn Goucher and Jon Varley have joined their executive leadership team.

Key Points: 
  • CALGARY, Alberta, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Tetra Trust Company, Canadas only regulated financial institution focused on cryptocurrency assets, announced today that Glenn Goucher and Jon Varley have joined their executive leadership team.
  • Jon Varley is a highly respected equities trader with a strong background in sales and trading.
  • Glenn and Jon are both experienced, strategic corporate leaders who will support Tetras market leadership as the only regulated custodian in the cryptocurrency market, said Eric Richmond, CEO of Tetra Trust.
  • Founded in 2019, Tetra Trust Company is Canadas First Qualified Custodian for cryptocurrency assets.